Gabriele Morabito

🚀 We’re excited to join the Inspired Community with Symbiotica Therapeutics! At Symbiotica Therapeutics, we are developing a new paradigm for biologic drug delivery. Our proprietary platform enables the long-term release of therapeutic proteins and peptides from a single subcutaneous administration, reducing the need for frequent injections and improving both safety and patient adherence. We often describe it as a “therapeutic tattoo”: once administered, the system remains localized and continuously delivers low, steady therapeutic doses into the bloodstream. This approach addresses some of the biggest challenges in modern biologic therapies: short half-life, side effects, high costs, and poor adherence and it opens the door to more effective treatments for chronic and high-impact diseases. 🔬 What we’ve achieved so far - In vivo proof of concept with strong efficacy, durability, and safety - Patent filed, with international extension planned - Selection for a competitive European innovation grant (SPRIND) supporting IND-enabling preclinical studies - A multidisciplinary, international team combining scientific, clinical, regulatory, and entrepreneurial expertise 💡 Why your vote matters The Inspired Contest is a powerful way to support early, science-driven innovation. Every vote helps us gain visibility, build momentum, and accelerate the path toward clinical impact. 👉 If you believe in long-term, patient-friendly therapies and breakthrough biotech innovation, we’d be grateful for your vote! Thank you for supporting Symbiotica Therapeutics!!